Cancer awareness in atypical thrombotic microangiopathies. (1/86)

Pathogenesis of thrombotic microangiopathy: insights from animal models. (2/86)

Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome. (3/86)

A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection. (4/86)

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. (5/86)

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. (6/86)

Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy. (7/86)

A patient with SLE-associated thrombotic microangiopathy and non-neutralizing antibodies against ADAMTS13. (8/86)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10